Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 9;24(1):601.
doi: 10.1186/s12905-024-03445-w.

Vitamin D has therapeutic effects on obesity and hyperandrogenemia in PCOS mouse model induced by low dose DHEA and high-fat diet

Affiliations

Vitamin D has therapeutic effects on obesity and hyperandrogenemia in PCOS mouse model induced by low dose DHEA and high-fat diet

Huiling Xu et al. BMC Womens Health. .

Abstract

Polycystic ovary syndrome (PCOS) is the most complex and common reproductive endocrine disease among reproductive age women. This study aimed to investigate the effects of vitamin D (Vit.D) in a PCOS mouse model induced by low dose DHEA and high-fat diet. Prepubertal female mice were divided into 4 groups randomly: control, PCOS, PCOS with low dose Vit.D(LDVD), and PCOS with high dose Vit.D(HDVD) groups (n = 10 per group). PCOS mice were administrated with high-fat diet and subcutaneous injection with 6 mg/kg/day dehydroepiandrosterone throughout the study. After the first 30 days, 1,25(OH)2D3 was intend to be administered by intraperitoneal injection for 40 consecutive days, 1.3 µg/kg/week in LDVD group, and 13 µg/kg /week in HDVD group. However, the mice in HDVD group appeared to be fatigue and anorexic after the Vit.D injections, then all died within two weeks. The body weights and testosterone levels in PCOS group were significantly higher than those in the control and LDVD groups (P < 0.001). The total cholesterol levels in the control group were lower than those in PCOS and LDVD groups (P < 0.001). Further, the ratio of liver to body weight was different among groups (P < 0.001). Our data illustrates that Vit.D has therapeutic effects on obesity and hyperandrogenemia in PCOS mouse model induced by low dose DHEA and high-fat diet. However, over dose of Vit.D is toxic. Further researches are needed to elucidate the mechanisms.

Keywords: Hyperandrogenemia; Obesity; Polycystic ovary syndrome; Vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Estrous cycle and ovaries of different groups of mice. (A) Representative estrous cycle pattern from each group. P, proestrus; E, estrus; M, metestrus; D, diestrus. (B) Ovary weight. (C) Ratio of ovary to body weight. (D) Representative H&E staining of ovarian sections. Micrographs were taken at magnifications ×25, ×100, and ×400, and bars = 500, 125, and 31.3 μm, respectively. The boxed areas are shown at higher magnifications. Black asterisk, corpora lutea
Fig. 2
Fig. 2
Livers of different groups of mice. (A) Gross morphology. (B) Liver weight. (C) Ratio of liver to body weight. # P < 0.05 vs. control group; ^ P < 0.05 vs. PCOS group. * P < 0.05 vs. LDVD group
Fig. 3
Fig. 3
Body weight of different groups of mice. * P < 0.05 vs. control; # P < 0.05 vs. PCOS

Similar articles

References

    1. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14:270–84. 10.1038/nrendo.2018.24. - PubMed
    1. Zhang J, et al. Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: a systematic analysis from the global burden of Disease Study 2019. PLoS ONE. 2024;19:e0306991. 10.1371/journal.pone.0306991. - PMC - PubMed
    1. Ding H, et al. Resistance to the insulin and elevated level of androgen: a Major cause of polycystic ovary syndrome. Front Endocrinol. 2021;12:741764. 10.3389/fendo.2021.741764. - PMC - PubMed
    1. Sen B, et al. Evaluation of oxidative stress and inflammation in patients with polycystic ovary syndrome. Obstet Gynecol Sci. 2024;67:414–20. 10.5468/ogs.24031. - PMC - PubMed
    1. Mimouni NEH, Giacobini P. Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome. CR Biol. 2024;347:19–25. 10.5802/crbiol.147. - PubMed

LinkOut - more resources